Regenerative Medical Technology Group Inc. Appoints Former Health Minister Dr. José Luis Décima to Lead Expansion in Northern Argentina and Paraguay

Reuters07-29
<a href="https://laohu8.com/S/RMTG">Regenerative Medical Technology Group Inc.</a> Appoints Former Health Minister Dr. José Luis Décima to Lead Expansion in Northern Argentina and Paraguay

Regenerative Medical Technology Group Inc. (RMTG) has appointed Dr. José Luis Décima as its new representative for Northern Argentina and Paraguay through its Global Stem Cells Group subsidiary. This strategic move aims to expand RMTG's affiliate network into these underserved markets with significant growth potential. Dr. Décima, a former Minister of Health for the province of Formosa, brings extensive institutional experience to lead the development of regional centers, training programs, and product distribution networks as part of RMTG's Latin American expansion strategy.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Regenerative Medical Technology Group Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 1054122) on July 29, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment